Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,839 | -47,939 | -18,518 | -10,121 | -8,556 |
| Depreciation Amortization | 861 | 848 | 740 | 776 | 828 |
| Accounts payable and accrued liabilities | 1,384 | -97 | 116 | -216 | 831 |
| Other Working Capital | 3,447 | 1,388 | 6,147 | -5,034 | 616 |
| Other Operating Activity | 8,348 | 11,036 | 571 | -1,142 | -2,585 |
| Operating Cash Flow | $-48,799 | $-34,764 | $-10,944 | $-15,737 | $-8,866 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,134 | -2,013 | -413 | -120 | -501 |
| Purchase Of Investment | -36,129 | -82,627 | N/A | N/A | N/A |
| Sale Of Investment | 70,000 | 9,995 | N/A | N/A | N/A |
| Other Investing Activity | 264 | -1,116 | 0 | 0 | 0 |
| Investing Cash Flow | $33,001 | $-75,761 | $-413 | $-120 | $-501 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,000 | N/A | 8,609 |
| Debt Repayment | N/A | -5,026 | -4,140 | -2,970 | -1,424 |
| Common Stock Issued | 45,865 | 95,023 | 46 | 7 | 70 |
| Common Stock Repurchased | N/A | N/A | -5 | N/A | N/A |
| Other Financing Activity | -76 | 0 | 55,381 | 0 | 0 |
| Financing Cash Flow | $45,789 | $89,997 | $54,282 | $-2,963 | $7,255 |
| Beginning Cash Position | 26,067 | 46,595 | 3,670 | 22,490 | 24,602 |
| End Cash Position | 56,058 | 26,067 | 46,595 | 3,670 | 22,490 |
| Net Cash Flow | $29,991 | $-20,528 | $42,925 | $-18,820 | $-2,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,799 | -34,764 | -10,944 | -15,737 | -8,866 |
| Capital Expenditure | -1,134 | -2,013 | -413 | -120 | -501 |
| Free Cash Flow | -49,933 | -36,777 | -11,357 | -15,857 | -9,367 |